Wed, 15 Aug 2018 06:55:56 GMT
Aridis Pharmaceuticals shares surge in US market debut
Aridis Pharmaceuticals, the biotechnology company, have surged as much as 5.4% to $13.70 in the firm's US market debut this Tuesday, bringing its market value to $102.7M at the opening price.